1127 related articles for article (PubMed ID: 30410101)
21. Liquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers.
Venesio T; Siravegna G; Bardelli A; Sapino A
Pathobiology; 2018; 85(1-2):146-154. PubMed ID: 28614831
[TBL] [Abstract][Full Text] [Related]
22. [Liquid biopsy in colorectal cancer : An overview of ctDNA analysis in tumour diagnostics].
Haupts A; Roth W; Hartmann N
Pathologe; 2019 Dec; 40(Suppl 3):244-251. PubMed ID: 31797045
[TBL] [Abstract][Full Text] [Related]
23. Clinical utility versus futility: a tipping point for liquid biopsies in bladder cancer.
Kouba E; Cheng L
Future Oncol; 2019 Nov; 15(33):3751-3753. PubMed ID: 31651200
[No Abstract] [Full Text] [Related]
24. Will liquid biopsies improve outcomes for patients with small-cell lung cancer?
Blackhall F; Frese KK; Simpson K; Kilgour E; Brady G; Dive C
Lancet Oncol; 2018 Sep; 19(9):e470-e481. PubMed ID: 30191851
[TBL] [Abstract][Full Text] [Related]
25. Liquid biopsy: possibilities and limitations in uro-oncology.
López-Guerrero JA; Pastor-Navarro B; Claramunt-Alonso R; García-Flores M; Rubio-Briones J
Arch Esp Urol; 2022 Mar; 75(2):203-214. PubMed ID: 35332890
[TBL] [Abstract][Full Text] [Related]
26. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
[TBL] [Abstract][Full Text] [Related]
27. Molecular Profiling of Liquid Biopsies for Precision Oncology.
Gonzalez-Kozlova EE
Adv Exp Med Biol; 2022; 1361():235-247. PubMed ID: 35230692
[TBL] [Abstract][Full Text] [Related]
28. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
Cheng F; Su L; Qian C
Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
[TBL] [Abstract][Full Text] [Related]
29. Fundamentals of liquid biopsies in metastatic prostate cancer: from characterization to stratification.
van Dessel LF; Martens JWM; Lolkema MP
Curr Opin Oncol; 2020 Sep; 32(5):527-534. PubMed ID: 32675591
[TBL] [Abstract][Full Text] [Related]
30. Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples.
Russano M; Napolitano A; Ribelli G; Iuliani M; Simonetti S; Citarella F; Pantano F; Dell'Aquila E; Anesi C; Silvestris N; Argentiero A; Solimando AG; Vincenzi B; Tonini G; Santini D
J Exp Clin Cancer Res; 2020 May; 39(1):95. PubMed ID: 32460897
[TBL] [Abstract][Full Text] [Related]
31. Emerging concepts in liquid biopsies.
Perakis S; Speicher MR
BMC Med; 2017 Apr; 15(1):75. PubMed ID: 28381299
[TBL] [Abstract][Full Text] [Related]
32. Potential of circulating biomarkers in liquid biopsy diagnostics.
Yeo JC; Lim CT
Biotechniques; 2018 Oct; 65(4):187-189. PubMed ID: 30284936
[No Abstract] [Full Text] [Related]
33. The relevance of liquid biopsy in surgical oncology: The application of perioperative circulating nucleic acid dynamics in improving patient outcomes.
Jordan PR; O'Leary DP; Fleming CA; Wang J; Redmond HP
Surgeon; 2022 Aug; 20(4):e163-e173. PubMed ID: 34362650
[TBL] [Abstract][Full Text] [Related]
34. Liquid Biopsy: From Basic Research to Clinical Practice.
Macías M; Alegre E; Díaz-Lagares A; Patiño A; Pérez-Gracia JL; Sanmamed M; López-López R; Varo N; González A
Adv Clin Chem; 2018; 83():73-119. PubMed ID: 29304904
[TBL] [Abstract][Full Text] [Related]
35. The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer.
Davidson BA; Croessmann S; Park BH
Br J Cancer; 2021 Sep; 125(6):780-788. PubMed ID: 34040179
[TBL] [Abstract][Full Text] [Related]
36. Liquid Biopsy: A New Tool in Oncology.
Costa JL; Schmitt FC
Acta Cytol; 2019; 63(6):448. PubMed ID: 31266005
[No Abstract] [Full Text] [Related]
37. Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.
Nordgård O; Tjensvoll K; Gilje B; Søreide K
Br J Surg; 2018 Jan; 105(2):e110-e120. PubMed ID: 29341153
[TBL] [Abstract][Full Text] [Related]
38. Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance.
Kilgour E; Rothwell DG; Brady G; Dive C
Cancer Cell; 2020 Apr; 37(4):485-495. PubMed ID: 32289272
[TBL] [Abstract][Full Text] [Related]
39. Liquid biopsy and minimal residual disease - latest advances and implications for cure.
Pantel K; Alix-Panabières C
Nat Rev Clin Oncol; 2019 Jul; 16(7):409-424. PubMed ID: 30796368
[TBL] [Abstract][Full Text] [Related]
40. Liquid Biopsy: General Concepts.
Poulet G; Massias J; Taly V
Acta Cytol; 2019; 63(6):449-455. PubMed ID: 31091522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]